Medicare Enrolled

Dr. Irene Cruite, M.D.

Radiation Oncology · Spokane, WA
Practice pattern: Mixed Practice — Diverse clinical practice across multiple procedure types
Low-engagement
801 S STEVENS ST, Spokane, WA 99204
5093637788
In practice since 2010 (15 years)
NPI: 1346559739 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Cruite from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Cruite? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Cruite

Dr. Irene Cruite is a radiation oncology specialist in Spokane, WA, with 15 years of NPI registration. Based on federal Medicare data, Dr. Cruite performed 12,785 Medicare services across 2,061 unique beneficiaries.

Between the years covered by Open Payments, Dr. Cruite received a total of $20 from 1 pharmaceutical and/or device company across 1 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in radiation oncology. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Cruite is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 15 years in practice ▲ Top 11% volume in WA $20 industry payments

Medicare Practice Summary

Medicare Utilization ↗
12,785
Medicare services
Top 11% in WA for radiation oncology
2,061
Unique beneficiaries
$40
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~852 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Contrast dye for imaging (iodine-based)
A contrast agent containing 300-399 mg/ml of iodine used to enhance imaging studies. It is administered per milliliter to improve the visibility of internal structures.
9,250 $0 $1
MRI contrast dye injection (gadobutrol) 1,366 $0 $2
Chest X-ray, 1 view
An X-ray image of the chest taken from a single angle. This imaging test is used to visualize the structures within the chest cavity.
393 $6 $26
Nuclear medicine scan from skull base to mid-thigh with CT
A nuclear medicine imaging study covering the area from the base of the skull to the middle of the thighs, performed alongside a CT scan.
385 $463 $1,054
Chest X-ray, 2 views
An X-ray imaging test of the chest that captures two different angles to visualize the lungs, heart, and chest wall.
197 $18 $90
Gallium Ga-68 gozetotide diagnostic injection
A diagnostic injection of the radiopharmaceutical Gallium Ga-68 gozetotide (brand name Illuccix) used for imaging purposes.
180 $817 $1,261
CT scan of abdomen and pelvis with contrast
A CT scan that uses dye to create detailed images of the abdomen and pelvis. This imaging test helps doctors examine internal organs and structures in these areas.
106 $176 $689
Fluorodeoxyglucose f-18 fdg, diagnostic, per study dose, up to 45 millicuries 105 $281 $360
Technetium Tc-99m medronate diagnostic injection
An injection of Technetium Tc-99m medronate used for diagnostic imaging studies. The dose administered is up to 30 millicuries per study.
100 $12 $57
CT scan of chest blood vessels with contrast
A CT scan that uses contrast dye to create detailed images of the blood vessels in the chest.
98 $66 $272
Whole body bone and joint nuclear medicine scan
A nuclear medicine imaging test that uses a radioactive tracer to create pictures of the entire skeleton and joints. This scan helps evaluate bone health and detect abnormalities throughout the body.
89 $226 $1,231
Whole body nuclear medicine scan with CT
A combined imaging procedure using nuclear medicine and CT scans to visualize the entire body.
77 $323 $788
CT scan of chest with contrast
A computed tomography scan of the chest using a contrast dye to enhance the visibility of internal structures.
45 $66 $464
SPECT/CT scan, single area
A nuclear medicine imaging study that combines single-photon emission computed tomography (SPECT) with a concurrent CT scan to create detailed images of a single body area.
45 $376 $1,753
CT scan of abdomen and pelvis with contrast
A CT scan of the abdomen and pelvis using contrast dye before and after administration to visualize internal structures.
41 $258 $914
Nuclear stress test of heart muscle
A nuclear medicine imaging test that evaluates blood flow to the heart muscle at rest and during stress using a special camera.
41 $58 $224
CT scan of abdomen and pelvis, without contrast
A computed tomography scan that creates detailed images of the abdominal and pelvic organs. The procedure is performed without the use of intravenous contrast dye.
30 $137 $636
SPECT/CT nuclear medicine scan, multiple areas
A combined nuclear medicine and CT imaging study performed on at least two body areas or through separate acquisitions on the same day.
30 $689 $2,600
CT scan of chest, without contrast
A computed tomography scan of the chest area that uses X-rays to create detailed images without the use of contrast dye.
23 $37 $143
Abdominal X-ray, 1 view
An X-ray image of the abdomen taken from a single angle to visualize internal structures.
19 $6 $26
Injection of radioactive material for lymph node identification
A radioactive substance is injected to help locate lymph nodes during imaging procedures.
18 $26 $128
CT scan of abdominal and pelvic blood vessels with contrast
A computed tomography scan that uses contrast dye to visualize the blood vessels in the abdomen and pelvis.
17 $79 $312
Nuclear medicine stomach emptying study
A nuclear medicine test used to assess how quickly the stomach empties its contents.
15 $255 $1,156
Technetium Tc-99m sulfur colloid diagnostic injection
A diagnostic injection of Technetium Tc-99m sulfur colloid used for imaging studies. The dose administered is up to 20 millicuries per study.
15 $211 $379
MRI of abdomen with and without contrast
An MRI scan of the abdomen using contrast dye before and after administration to create detailed images of internal structures.
14 $248 $2,400
Nuclear medicine kidney study with drug administration
A nuclear medicine test that evaluates kidney blood flow and function using a radioactive tracer and drug administration.
13 $150 $637
Ultrasound of arm or leg veins
An ultrasound exam of the veins in one arm or leg using compression and other maneuvers to assess blood flow and check for blockages.
13 $15 $65
Hip X-ray, 2-3 views
An X-ray imaging test of the hip joint using two to three different angles to visualize the bones and surrounding structures.
12 $9 $35
Bone scan with multiple time points
A nuclear medicine imaging test that captures images of the bones at various intervals to assess bone health and detect abnormalities.
12 $249 $1,300
Lung ventilation and perfusion scan
A nuclear medicine test that uses radioactive tracers to evaluate both air flow (ventilation) and blood flow (perfusion) in the lungs.
12 $251 $1,300
Technetium Tc-99m MAA diagnostic injection
A radioactive tracer injection used for diagnostic imaging studies. The dose administered is up to 10 millicuries.
12 $27 $50
Technetium tc-99m pentetate, diagnostic, aerosol, per study dose, up to 75 millicuries 12 $139 $177
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
0.1% high complexity
94.0% medium
5.9% routine

Industry Payment Transparency

Open Payments through 2024 ↗
$20
Total received (2024-2024)
Bottom 12% in WA for radiation oncology
1
Company
1
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$20 (100.0%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$20

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
Telix Pharmaceuticals
$20
Top 3 companies account for 100.0% of 2024 payments
Associated products mentioned in payments ›
ILLUCCIX
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

Most payments (100%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.

Looking for a radiation oncology specialist in Spokane?
Compare radiation oncologists in the Spokane area by procedure volume, costs, and industry payment transparency.
Browse radiation oncologists nearby

Geographic Context

Radiation oncologists within 10 mi
104
Per 100K population
19.1
County median income
$73,513
Nearest hospital
SHRINERS HOSPITAL FOR CHILDREN
0.0 mi

Data Sources

Provider Registry NPPES Weekly updates
Medicare Enrollment PECOS Monthly updates
Practice Data Medicare Util. Annual (CY lag)
Industry Payments Open Payments CY 2024
Disciplinary History — Not public N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →

Summary

Dr. Cruite is a mixed practice specialist, with above-average Medicare volume (top 11% in WA), with low-engagement industry engagement, with 15 years of NPI registration.

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Is Dr. Cruite experienced with contrast dye for imaging (iodine-based)?
Based on Medicare claims data, Dr. Cruite performed 9,250 contrast dye for imaging (iodine-based) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Cruite receive payments from pharmaceutical companies?
Yes. Dr. Cruite received a total of $20 from 1 company across 1 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Cruite's costs compare to other radiation oncologists in Spokane?
Dr. Cruite's average Medicare payment per service is $40. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Cruite) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →